CMS certification 280040
The Nebraska Methodist Hospital
8303 Dodge St, Omaha, NE 68114
The Nebraska Methodist Hospital has a CMS overall rating of 4 out of 5 stars. 84% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. Emergency patients spend a median of 2 h 36 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,588 completed surveys, 26% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NE | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 350 visits sampled · US median for EDs of the same volume: 3 h 22 min | 2 h 36 min | 1 h 53 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 21 visits sampled | 4 h 35 min | 2 h 41 min | 4 h 17 min |
| Left before being seen Lower is better · 54,098 patients | 2% | 1% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 11 patients | 55% | 60% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 190 patients | 62% | 64% | 65% |
How The Nebraska Methodist Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| The Nebraska Methodist HospitalThis hospital | 4/5 | 84% | 2 h 36 min | 5 better 1 worse |
| Midwest Surgical Hospital LLCSame city | Not rated | 87% | — | 1 worse |
| Chi Health ImmanuelSame city | 3/5 | 63% | 2 h 8 min | 3 better 1 worse |
| Nebraska Spine Hospital, LLCSame city | Not rated | 85% | — | No different |
| Omaha VA Medical Center (VA Nebraska Western Iowa Healthcare System)Same city | 4/5 | 72% | — | 1 better |
| Chi Health Bergan MercySame city | 4/5 | 62% | 2 h 36 min | 4 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Omaha.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,027 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 207 cases | Too few cases | 11% | 11.9% |
| Heart failure 577 cases | Too few cases | 11% | 11.1% |
| Pneumonia 646 cases | Too few cases | 14.7% | 15.2% |
| Stroke 281 cases | Too few cases | 10.1% | 11.9% |
| COPD 239 cases | Too few cases | 7.6% | 8.6% |
| Heart bypass surgery (CABG) 208 cases | Too few cases | 1.6% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.04 likely 0.81 – 1.28 | 1 |
| After hip or knee replacement 283 cases | Too few cases | 3.7% | 4.1% |
| Deaths after a serious but treatable surgical complication 144 cases | No different | 191.37 per 1,000 likely 147.65 per 1,000 – 235.1 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 7,904 cases | No different | 0.48 per 1,000 likely 0 per 1,000 – 1.02 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 9,430 cases | Worse | 0.41 per 1,000 likely 0.23 per 1,000 – 0.59 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 10,276 cases | No different | 0.31 per 1,000 likely 0.13 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,212 cases | Worse | 5.52 per 1,000 likely 4.37 per 1,000 – 6.68 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 2,249 cases | No different | 2.04 per 1,000 likely 0.81 per 1,000 – 3.27 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,998 cases | No different | 12.01 per 1,000 likely 7.92 per 1,000 – 16.1 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,571 cases | No different | 2.95 per 1,000 likely 1.37 per 1,000 – 4.54 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 2,123 cases | No different | 3.19 per 1,000 likely 0.75 per 1,000 – 5.63 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 924 cases | No different | 1.35 per 1,000 likely 0.01 per 1,000 – 2.7 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,550 cases | No different | 1.72 per 1,000 likely 0.97 per 1,000 – 2.46 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.54 likely 0.22 – 1.13 | 1 |
| Surgical site infections after colon surgery | No different | 0.83 likely 0.44 – 1.44 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.81 likely 0.33 – 1.69 | 1 |
| MRSA bloodstream infections | No different | 0.49 likely 0.13 – 1.34 | 1 |
| C. diff intestinal infections | Better | 0.41 likely 0.27 – 0.59 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 255 cases | Too few cases | 15.7% | 14.4% |
| Readmitted after heart failure 809 cases | Too few cases | 23.2% | 21.3% |
| Readmitted after pneumonia 833 cases | Too few cases | 18.2% | 17.3% |
| Readmitted after COPD 371 cases | Too few cases | 19.4% | 20% |
| Readmitted after heart bypass surgery 175 cases | Too few cases | 10.4% | 11% |
| Readmitted after hip or knee replacement 255 cases | Too few cases | 7% | 5.8% |
| Days back in hospital after a heart attack 236 cases | Too few cases | 2.8 days per 100 | — |
| Days back in hospital after heart failure 639 cases | Too few cases | -5.1 days per 100 | — |
| Days back in hospital after pneumonia 649 cases | Too few cases | -8.8 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,304 cases | No different | 13.3 per 1,000 likely 10.6 per 1,000 – 16.9 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 95 cases | No different | 10.9 per 100 likely 7.8 per 100 – 15.1 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 95 cases | No different | 4.7 per 100 likely 3.1 per 100 – 7.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,935 cases | No different | 1 likely 0.8 – 1.1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
236 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Practitioner | 42 |
| Hospitalist | 32 |
| Emergency Medicine | 22 |
| Anatomic Pathology & Clinical Pathology | 21 |
| Physician Assistant | 15 |
| Nurse Anesthetist, Certified Registered | 9 |
| Pharmacist | 9 |
| Dietitian, Registered | 7 |
| Family | 7 |
| Hematology & Oncology | 7 |
| Plastic Surgery within the Head & Neck | 5 |
| Radiation Oncology | 5 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $608,929
- 2020 $492,826
- 2021 $823,472
- 2022 $593,239
- 2023 $721,348
- 2024 $928,257
- 2025 $272,453
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Education | $2,798 | 1 |
| Medical devices and supplies on long-term loan | $2,663 | 23 |
| Debt forgiveness | $2,539 | 6 |
| Speaking, teaching and other services | $550 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Aadi Bioscience, Inc. | $108,430 | 3 |
| Servier BioInnovation | $50,000 | 9 |
| Genentech, Inc. | $32,910 | 8 |
| Regeneron Pharmaceuticals, Inc. | $27,184 | 18 |
| Eli Lilly and Company | $22,534 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,646 | 7 |
| Abbvie INC. | $4,759 | 4 |
| Intuitive Surgical, INC. | $2,798 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic In… Aadi Bioscience, Inc. · NCT05103358 | $108,430 |
| Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or meta… Servier BioInnovation | $50,000 |
| A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARAS Genentech, Inc. | $29,000 |
| EMBER-4: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ADJUVANT IMLUNESTRANT VS STANDARD ADJUVANT ENDOCRINE THERAPY IN PATIENTS WHO HAVE PREVIOUSLY RECE… Eli Lilly and Company · NCT05514054 | $21,995 |
| A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ADJUVANT CEMIPLIMAB VERSUS PLACEBO AFTER SURGERY AND RADIATION THERAPY IN PATIENTS WITH HIGH … Regeneron Pharmaceuticals, Inc. · NCT03969004 | $17,684 |
| Brightline-4: A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of BI 907828 (Brigimadlin) treatment in patien… Boehringer Ingelheim Pharmaceuticals, Inc. | $12,646 |
| Testing the Addition of an Immunotherapy Drug, Cemiplimab, Before Surgery to Up-front Surgery for Advanced Skin Cancer Regeneron Pharmaceuticals, Inc. | $9,500 |
| Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLO… ABBVIE INC. · NCT05445778 | $4,759 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about The Nebraska Methodist Hospital
Is The Nebraska Methodist Hospital a good hospital?
The Nebraska Methodist Hospital has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend The Nebraska Methodist Hospital?
84% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,588 completed HCAHPS surveys.
How long is the wait in the The Nebraska Methodist Hospital emergency room?
Emergency patients spend a median of 2 h 36 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does The Nebraska Methodist Hospital receive money from drug and device companies?
Drug and device makers reported $272,453 in payments to The Nebraska Methodist Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.